Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Catalyst Pharmaceuticals, Inc. CPRX
$13.54
-$0.59 (-4.35%)
На 18:00, 12 мая 2023
+43.13%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
1532427420.00000000
-
week52high
22.11
-
week52low
6.15
-
Revenue
214203000
-
P/E TTM
22
-
Beta
1.11176400
-
EPS
0.78000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 20:00
Описание компании
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Roth Capital | Neutral | Buy | 24 авг 2022 г. |
| Truist Securities | Buy | Buy | 11 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 11 авг 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 08 февр 2022 г. |
| Roth Capital | Buy | Buy | 18 мар 2021 г. |
| Truist Securities | Buy | Buy | 21 дек 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 21 дек 2022 г. |
| Piper Sandler | Overweight | Overweight | 20 дек 2022 г. |
| Truist Securities | Buy | Buy | 19 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| DENKHAUS DONALD A | D | 264500 | 50000 | 24 янв 2023 г. |
| DENKHAUS DONALD A | A | 329000 | 50000 | 24 янв 2023 г. |
| O'Keeffe Charles B | D | 264500 | 50000 | 24 янв 2023 г. |
| O'Keeffe Charles B | A | 616391 | 50000 | 24 янв 2023 г. |
| MCENANY PATRICK J | D | 3901307 | 10000 | 29 дек 2022 г. |
| MCENANY PATRICK J | D | 3911307 | 10000 | 28 дек 2022 г. |
| Del Carmen Jeffrey | A | 721983 | 26000 | 27 дек 2022 г. |
| Del Carmen Jeffrey | A | 695983 | 88000 | 27 дек 2022 г. |
| DENKHAUS DONALD A | A | 314500 | 4000 | 27 дек 2022 г. |
| DENKHAUS DONALD A | A | 310500 | 15000 | 27 дек 2022 г. |
Новостная лента
Should You Invest in Catalyst (CPRX) Based on Bullish Wall Street Views?
Zacks Investment Research
12 мая 2023 г. в 10:39
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
3 Reasons Growth Investors Will Love Catalyst (CPRX)
Zacks Investment Research
26 апр 2023 г. в 14:26
Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.
Catalyst Pharmaceuticals to Report First Quarter 2023 Financial Results on May 10, 2023
GlobeNewsWire
24 апр 2023 г. в 08:03
The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET The Company Will Host a Conference Call and Webcast on May 11, 2023, at 8:30 AM ET
Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task
Seeking Alpha
19 апр 2023 г. в 07:51
Catalyst Pharmaceuticals: Fixing Its Misnomer Is No Easy Task
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread
Seeking Alpha
18 апр 2023 г. в 12:00
Catalyst Pharma And Teva's ANDA Challenge: Firdapse Hangs By A Thread